Achim A Jungbluth
Overview
Explore the profile of Achim A Jungbluth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
199
Citations
11153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Hernandez E, Frosina D, Ruh P, Ariyan C, Busam K, et al.
Am J Dermatopathol
. 2024 Jul;
46(9):563-571.
PMID: 39008470
Melanocyte differentiation antigens refer to molecules expressed in cells of melanocytic lineage such as gp100/PMEL, tyrosinase, and Melan-A. Corresponding antibodies such as HMB45, T311, and A103 have become key immunohistochemical...
2.
Zaidi S, Park J, Chan J, Roudier M, Zhao J, Gopalan A, et al.
Proc Natl Acad Sci U S A
. 2024 Jul;
121(28):e2322203121.
PMID: 38968122
Targeting cell surface molecules using radioligand and antibody-based therapies has yielded considerable success across cancers. However, it remains unclear how the expression of putative lineage markers, particularly cell surface molecules,...
3.
Gupta A, Gazzo A, Selenica P, Safonov A, Pareja F, da Silva E, et al.
bioRxiv
. 2024 May;
PMID: 38746158
Acquired genetic alterations commonly drive resistance to endocrine and targeted therapies in metastatic breast cancer , however the underlying processes engendering these diverse alterations are largely uncharacterized. To identify the...
4.
Blanco-Heredia J, Souza C, Trincado J, Gonzalez-Cao M, Goncalves-Ribeiro S, Gil S, et al.
Nat Commun
. 2024 Feb;
15(1):1302.
PMID: 38383522
The interactions between tumor and immune cells along the course of breast cancer progression remain largely unknown. Here, we extensively characterize multiple sequential and parallel multiregion tumor and blood specimens...
5.
Febres-Aldana C, Chang J, Jungbluth A, Adusumilli P, Bodd F, Frosina D, et al.
Mod Pathol
. 2024 Jan;
37(3):100420.
PMID: 38185249
9p21 deletions involving MTAP/CDKN2A genes are detected in diffuse pleural mesotheliomas (DPM) but are absent in benign mesothelial proliferations. Loss of MTAP expression by immunohistochemistry (IHC) is well accepted as...
6.
Lezcano C, Jungbluth A, Busam K
Am J Dermatopathol
. 2023 Oct;
45(11):733-747.
PMID: 37856737
Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated antigen first identified in a melanoma patient and found to be expressed in most melanomas as well as in variable levels...
7.
Redelman-Sidi G, Binyamin A, Antonelli A, Catalano W, Bean J, Al-Ahmadie H, et al.
Cancer Immunol Res
. 2022 Aug;
10(10):1241-1253.
PMID: 36040405
For decades, BCG immunotherapy has been the standard of care for non-muscle-invasive bladder cancer. Despite this clinical experience, the mechanism by which BCG stimulates tumor-eliminating immunity is unclear, and there...
8.
Baine M, Febres-Aldana C, Chang J, Jungbluth A, Sethi S, Antonescu C, et al.
J Thorac Oncol
. 2022 Jun;
17(9):1109-1121.
PMID: 35760287
Introduction: POU2F3 is a recent marker of a small cell lung carcinoma (SCLC) subtype related to chemosensory tuft cells (SCLC-P). The characteristics of SCLC-P have not been fully defined, and...
9.
Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3
Zhong E, Pareja F, Hanna M, Jungbluth A, Rekhtman N, Brogi E
Hum Pathol
. 2022 Jun;
127:102-111.
PMID: 35690220
INSM1, ASCL1, and POU2F3 are novel transcription factors involved in neuroendocrine (NE) differentiation of neoplasms in several organs, but data on their expression in breast carcinomas (BCs) are limited. We...
10.
Haidari S, Troltzsch M, Fliefel R, Jungbluth A, Otto S, Fegg F, et al.
J Oral Pathol Med
. 2022 Apr;
51(5):421-428.
PMID: 35430758
Background: The objective was to assess the expression patterns of the cancer testis antigen PRAME, NY-ESO1, and SSX2 in oral squamous cell carcinoma (OSSC) and to correlate the expression with...